INTRANASAL OXYTOCIN ADMINISTRATION PRIOR TO EXPOSURE THERAPY FOR ARACHNOPHOBIA IMPEDES TREATMENT RESPONSE

Publisher： John Wiley & Sons Inc

E-ISSN： 1520-6394|32|6|400-407

ISSN： 1091-4269

Source： DEPRESSION AND ANXIETY (ELECTRONIC), Vol.32, Iss.6, 2015-06, pp. : 400-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TAKING THE PULSE OF PROLONGED EXPOSURE THERAPY: PHYSIOLOGICAL REACTIVITY TO TRAUMA IMAGERY AS AN OBJECTIVE MEASURE OF TREATMENT RESPONSE

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 12, 2015-12 ,pp. : 927-934

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergy Therapy by Intranasal Administration with Recombinant Lactococcus lactis Producing Bovine β-Lactoglobulin

By  

International Archives of Allergy and Immunology, Vol. 150, Iss. 1, 2009-04 ,pp. : 25-31

Karger

Access to resources Recommend Favorite

Improved exposure for the intranasal ethmoidectomy or sphenoethmoidectomy

By  

THE LARYNGOSCOPE, Vol. 94, Iss. 1, 1984-01 ,pp. : 123-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intranasal Administration of CpG Induces a Rapid and Transient Cytokine Response Followed by Dendritic and Natural Killer Cell Activation and Recruitment in the Mouse Lung

By  

Journal of Innate Immunity, Vol. 2, Iss. 2, 2009-10 ,pp. : 144-159

Karger

Access to resources Recommend Favorite

Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy

By Cosman F.   Nieves J.   Zion M.   Barbuto N.   Lindsay R.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite